Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.75
Bid: 1.70
Ask: 1.80
Change: 0.00 (0.00%)
Spread: 0.10 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.75
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Kinovo rises as results ahead of expectations

Fri, 24th May 2024 10:37

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Kinovo PLC, up 8.1% at 60.00 pence, 12-month range 38.50p-70.00p. Shares in the provider of safety and regulatory compliance services for the property sector rise. Kinovo expects to report a full year performance ahead of prior expectations. Anticipates profit from continuing operations to rise by 15% to GBP18.9 million from March 31 from GBP16.5 million a year earlier. Earnings before interest, tax, depreciation and amortisation to rise by 23% to GBP6.7 million from GBP5.5 million, ahead of expectations of GBP6.2 million. Pretax profit are eyed up to GBP6.1 million from GBP4.9 million.

----------

Genedrive PLC, up 9.9% to 1.84p, 12-month range 1.21p-18.98p. The pharmacogenetic testing company says that initial orders have been received for the Genedrive MT-RNR1 products from a further five UK hospitals in the Greater Manchester region. The total value of the orders is over GBP100,000. Chief Executive James Cheek says: "I am delighted to see the positive effects of our direct to customer commercialisation strategy in the UK, with further NHS engagement and uptake for bringing this vital test which has the potential to avoid profound, irreversible hearing loss in babies in neonatal care units into day-to-day use in neonatal emergency care. Our expectation is that more NHS trusts will adopt this simple to use point of care genetic test in the coming months and we continue to grow our opportunities overseas."

----------

AIM - LOSERS

----------

Goldstone Resources Ltd, down 62% at 0.88p, 12-month range 0.78p-3.30p. Shares in the gold producer and explorer fall, as suspension on trading is lifted. It says it has raised GBP834,000 through a fundraising of shares. "The board believes that the fundraise, in conjunction with the group's ongoing revenues and creditor arrangements, provides sufficient working capital for continued operations," Goldstone adds.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
5 Oct 2022 11:40

Genedrive shares surge as pre-submission for MT-RNR1 filed to FDA

(Alliance News) - Genedrive PLC on Wednesday said it has started engagement with the US Food & Drug Administration to progress the approval of its MT-RNR1 product range into the US.

Read more
5 Oct 2022 11:03

Genedrive engages with US FDA over infant test

(Sharecast News) - Near-patient molecular diagnostics company Genedrive has started engaging with the US Food and Drug Administration (FDA), it announced on Wednesday, to progress the regulatory approval of its 'MT-RNR1 ID Kit' into the United States.

Read more
26 Sep 2022 14:24

Genedrive says its "world first" test has been accelerated by NICE

(Alliance News) - Genedrive PLC on Monday said that its Genedrive MT-RNR1 test has been accelerated by the UK's National Institute for Health & Clinical Excellence.

Read more
26 Sep 2022 14:10

Genedrive test to go through new, faster NICE process

(Sharecast News) - Molecular diagnostics technology company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has transferred the evaluation of its 'MT-RNR1' test to a new 'early value assessment programme'.

Read more
22 Aug 2022 11:48

Genedrive's CYP2C19 ID Kit included in UK's NICE assessment

(Alliance News) - Genedrive PLC on Monday said the UK's National Institute for Health & Clinical Excellence has begun an evaluation of CYP2C19 genotype testing for Clopidogrel treatment.

Read more
22 Aug 2022 10:39

Another Genedrive test to be assessed by NICE

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has started an evaluation of CYP2C19 genotype testing for clopidogrel treatment, via a new NICE diagnostics assessment programme (DAP).

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
16 Jun 2022 14:42

Genedrive test to be evaluated by NICE

(Sharecast News) - Molecular diagnostics company Genedrive announced on Thursday that the UK's National Institute for Health and Clinical Excellence (NICE) has started an evaluation of the Genedrive MT-RNR1 test, via its Diagnostics Assessment Programme (DAP).

Read more
30 May 2022 18:14

IN BRIEF: Genedrive Covid-19 test receives CTDA approval in UK

Genedrive PLC - Manchester-based molecular diagnostics company - Says the UK Medicines & Healthcare Products Regulatory Agency has granted a coronavirus test device approval enabling the sale of the Genedrive COV19-ID Kit in the UK. Genedrive's application for approval was made on December 21.

Read more
29 Mar 2022 17:05

TRADING UPDATES: Solid 2021 for Ten Entertainment, Central Asia Metals

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Mar 2022 13:04

Genedrive rallies on positive news about hearing loss test

(Sharecast News) - Molecular diagnostics company Genedrive rallied on Tuesday after the UK's National Institute of Clinical Excellence (NICE) issued a new Medtech Innovation Briefing on its MT-RNR1 hearing loss test.

Read more
29 Mar 2022 10:32

Genedrive soars as UK public health body reviews hearing loss test

(Alliance News) - Genedrive PLC said on Tuesday that the UK National Institute of Clinical Excellence gave the company's MT-RNR1 hearing loss test a new Medtech Innovation Briefing.

Read more
22 Mar 2022 16:09

UK earnings, trading statements calendar - next 7 days

Wednesday 23 March 
Dignity PLCFull Year Results
ECSC Group PLCFull Year Results
Halma PLCTrading Statement
Surgical Innovations Group PLCFull Year Results
Henry Boot PLCFull Year Results
Judges Scientific PLCFull Year Results
Pendragon PLCFull Year Results
Saga PLCFull Year Results
SigmaRoc PLCFull Year Results
Ultra Electronics Holdings PLCFull Year Results
Petrofac LtdFull Year Results
Thursday 24 March 
Arbuthnot Banking Group PLCFull Year Results
Atalaya Mining PLCFull Year Results
Big Technologies PLCFull Year Results
Biome Technologies PLCFull Year Results
Bridepoint Group PLCFull Year Results
CVS Group PLCHalf Year Results
Energean PLCFull Year Results
EnQuest PLCFull Year Results
Eve Sleep PLCFull Year Results
International Public Partnerships LtdFull Year Results
Kin & Carta PLCFull Year Results
Next PLCFull Year Results
Robinson PLCFull Year Results
Safestyle UK PLCFull Year Results
Secure Trust Bank PLCFull Year Results
Sopheon PLCFull Year Results
Starwood European Real Estate LtdFull Year Results
WAG Payment Solutions PLCFull Year Results
Friday 25 March 
Electrocomponents PLCTrading Statement
Faron Pharmaceuticals LtdFull Year Results
Smiths Group Half Year Results
United Utilities Group PLCTrading Statement
Wickes Group PLCFull Year Results
Monday 28 March 
Dialight PLCFull Year Results
Hercules Site Services PLCFull Year Results
RTC Group PLCFull Year Results
LungLife AI IncFull Year Results
Octopus Renewables Infrastructure Trust PLCFull Year Results
Tuesday 29 March 
AG Barr PLCFull Year Results
Animalcare Group PLCFull Year Results
Aquis Exchange PLCFull Year Results
Artisanal Spirits Co PLCFull Year Results
Bellway PLCHalf Year Results
Burford Capital LtdFull Year Results
Central Asia Metals PLCFull Year Results
Ergomed PLCFull Year Results
FireAngel Safety Technology Group PLCFull Year Results
Genedrive PLCHalf Year Results
Good Energy Group PLCFull Year Results
IQE PLCFull Year Results
Mortgage Advice Bureau Holdings PLCFull Year Results
NAHL Group PLCFull Year Results
Personal Group Holdings PLCFull Year Results
RBG Holdings PLCFull Year Results
Regional REIT LtdFull Year Results
S&U PLCFull Year Results
SkinBioTherapeutics PLCHalf Year Results
SSE PLCTrading Statement
Ten Entertainment Group PLCFull Year Results
Xaar PLCFull Year Results
XLMedia PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Mar 2022 19:11

TRADING UPDATES: Kavango eyes acquisition; PYX ups zicron price

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Mar 2022 20:28

TRADING UPDATES: Elixirr buys in US; JPMorgan Russian wary of values

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.